Navigation Links
Reportlinker Adds Global Veterinary Vaccines Industry
Date:10/18/2010

NEW YORK, Oct. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Veterinary Vaccines Industry

http://www.reportlinker.com/p092485/Global-Veterinary-Vaccines-Industry.html

This report analyzes the worldwide markets for Veterinary Vaccines in US$ Million by the following Product segments: Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets. The report profiles 60 companies including many key and niche players such as Bayer HealthCare AG, Biogenesis-Bago, Fort Dodge Animal Health, Heska Corporation, Imugene Limited, Indian Immunologicals Ltd., Lohmann Animal Health, Merck & Co., Inc., Intervet/Schering-Plough Animal Health, Merial Ltd., Pfizer, Inc., Embrex, Inc., Protein Sciences Corporation, and Virbac Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

VETERINARY VACCINES MCP-1129

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 3

Quantitative Techniques & Analytics 3

Product Definitions and Scope of Study 3

A.Companion Animal Vaccines 4

B.Livestock Vaccines 4

Porcine Vaccines 4

Bovine Vaccines 4

Poultry Vaccines 4

Ovine Vaccines 4

Equine Vaccines 5

Other Animal Vaccines 5

2. INDUSTRY OVERVIEW & OUTLOOK 6

Global Animal Health Care Industry - A Brief Review 6

Table 1: Global Animal Health Products Market by Region

(2008): Percentage Share Breakdown by Value Sales for North

America, Europe, Latin America and Rest of World (includes

corresponding Graph/Chart) 6

Table 2: Global Animal Health Products Market by Product

Group (2008): Percentage Share Breakdown by Value sales for

Parasiticides, Vaccines, Anti-Infectives, Medical Feed

Additives and Other Pharmaceuticals (includes corresponding

Graph/Chart) 6

Animal Healthcare Market Grows Amidst Recession 7

Veterinary Vaccines Industry Posts Moderate Growth 7

Poultry Vaccines Industry: A Global Scenario 7

Improved Manufacturing Techniques 8

Improved Analysis 8

Scope of the Report 8

Current and Future Analysis 8

Analysis by Product Segment 9

Companion Animal Vaccines 9

Livestock Vaccines 9

Analysis by Region 9

Companion Animal Vaccines Market 9

Livestock Vaccines Market 9

3. MARKET TRENDS & ISSUES 10

Companion Animal Vaccines: Trailing on a High Growth Track 10

OTC Market: A Potential Threat for Veterinarians 10

Small Animal Practitioners Feel the Pinch of Recession 10

Parasiticides, Systemic Agents To Drive The Market 10

Taxonomy of Vaccines 10

Bird Flu - The Aftermath 11

Vaccination - Critical for Controlling Avian Influenza Virus 11

4. PRODUCT OVERVIEW 12

Vaccines - An Evolutionary Scan 12

Contribution of Animal Research to Vaccine Production 12

Veterinary Medicines- A Brief Review 13

Preventive Medicines 13

Therapeutic Medicines 13

Others 13

Development of Vaccines 13

Production of Vaccines 14

Veterinary Vaccines - An Essential Component of Animal Health

Care 14

What Does A Veterinary Vaccine Do? 15

Classification of Veterinary Vaccines 15

Companion Animals Vaccines 15

Canine Vaccines 15

Feline Vaccines 17

Livestock Vaccines 18

Bovine Vaccines 18

Poultry Vaccines 19

Ovine Vaccines 19

Porcine Vaccines 20

Equine Vaccines 20

Aquaculture Vaccines 20

A Tabular Analysis on Select Animal Diseases Controlled by

Vaccines 21

Vaccination and Its Reactions 21

Veterinary Vaccines- Latest Breakthroughs 21

Marker vaccines 21

DNA vaccines 21

Gene-deleted vaccines 22

Viral-vectored vaccines 22

5. NOTES ON SELECT ANIMAL DISEASES 23

Brucellosis 23

Tuberculosis 23

Johne's disease 23

Spirochete Associated Diseases 23

Respiratory Disease in Goats, Sheep, and Cattle 24

Porcine Respiratory Diseases 24

Mastitis 24

African Swine Fever 24

Avian Influenza 25

East Coast Fever 25

Hemorrhagic Septicemia 25

Foot-And-Mouth Disease 25

Japanese Encephalitis 25

Rift Valley Fever 26

Equine Virus 26

6. PRODUCT INNOVATIONS/INTRODUCTIONS 27

Intervet Schering Plough Animal Health Introduces Circovirosis

Vaccine 27

Pfizer Animal Health Develops Inovocox® Vaccine 27

Intervet/Schering-Plough Animal Health Launches Bravoxin 10 27

Bioject and Merial Rolls Out Derma-Vac NF 27

Defra to Launch Bovine Tuberculosis Vaccine 28

Intervet International Develops Bluetongue Vaccine 28

Hester Biosciences Unveils Anti-Coryza Vaccine 28

Intervet/Schering-Plough Animal Health Introduces Bovilis BTV8

Vaccine 28

Tecnovax Develops Vaccine for Salmon Virus 29

Tamil Nadu Veterinary and Animal Science University and The

Indian Veterinary Research Institute Develop Vaccine 29

Lohmann Animal Health Develops AviPro IBD Xtreme 29

Intervet/Schering-Plough Animal Health Launches EquiRab™ 29

Lohmann Animal Health Introduces Larger Doses of AviPro®

ViBursa CE 29

Lohmann Animal Health International Rolls Out AviBlue 30

Fort Dodge Animal Health Unveils West Nile-Innovator DNA 30

Univet Agricultural Products Introduces Coglapest 30

Intervet/Schering-Plough Animal Health Launches Porcilis® COLI 6C 31

Pfizer Animal Health Unveils FluSure® XP Defense System 31

Pfizer Animal Health Launches Improvac® 31

Intervet/Schering-Plough Animal Health Develops Onset™ 5

Intranasal (IN) Vaccine 31

Merial Rolls Out BTVPUR AlSap 8 32

Pfizer Animal Health Introduces FarrowSure® GOLD and

FarrowSure® GOLD B 32

Schering-Plough Animal Health Unveils CAVALRY 9 32

Lohmann Animal Health Develops BTO2 REO Vaccine 33

7. PRODUCT INNOVATIONS/INTRODUCTIONS IN RECENT PAST - A

PERSPECTIVE BUILDER 34

Agroinsuvet Introduces New Vaccines 34

Merial Rolls Out Vaxxitek® HVT+IBD Hatchery Vaccine for

Poultry Industry 34

Intervet & Friedrich-Loeffler-Institute Develop Dual Vaccine

Prototype for Birds 34

Schering-Plough Receives USDA License for its Rhusigen™

Erysipelas Vaccine 34

USDA Approves Use of PreveNile™ Vaccine for Horses 35

Fort Dodge Animal Health Develops Reverse Genetics Avian Vaccine 35

Boehringer Ingelheim's Swine Vaccine Gains Approval in Australia 35

Merial Limited Gets USDA Approval for DNA Vaccine for Melanoma

in Dogs 35

Embrex's Poultry Vaccine Inovocox Gets USDA Approval 36

Skystar Bio-Pharmaceutical Develops Avian Influenza Vaccine 36

United States Department of Agriculture Grants Conditional

License for Necrotic Enteritis Vaccine 36

Fort Dodge Receives USDA License for Pyramid®10 37

USDA Licenses Use of Fort Dodge's Suvaxyn® PCV2 Vaccine in Pigs 37

USDA Grants Conditional License to Pfizer's New Canine Vaccine 37

8. RECENT INDUSTRY ACTIVITY 38

Virbac Acquires 30% Share in Santa Elena 38

Merck and Sanofi-Aventis to Merge their Animal Health Business 38

Elanco to Take Over Pfizer's Animal Health Products Portfolio 38

Boehringer Ingelheim to Acquire Pfizer's Fort Dodge Animal

Health Unit 38

ImmunoVaccine Inks Deal with Pfizer 39

Merck Merges with Schering-Plough 39

Pfizer Acquires Wyeth 39

Merial Receives Marketing License for BTVPUR AlSap 8 Vaccine 40

Epitopix Obtains Approval to Sell Siderophore Receptor and

Porin Vaccine 40

Phibro Animal Health Acquires Animal Health Division of Abic 40

Fort Dodge Animal Health and Vivalis Sign Commercial License Deal 41

Hester Biosciences Expands Gujarat Based Facility 41

Intervet/Schering-Plough Animal Health Replaces Bovilis® IBR

Vaccine with Bovilis® IBR Marker Live 41

Tangshan Yian Biological Engineering Wins Approval from

Ministry of Agriculture of China 41

Lohmann Animal Health International Signs an Agreement with

Celldex Therapeutics 42

Intervet/Schering-Plough Animal Health Starts New

Manufacturing Facility 42

Laprovet Commences New Facility 42

ImmunoVaccine Technologies and La Jolla Institute for Allergy &

Immunology Enter into an Agreement 42

Merial Signs a Toll Distribution and Manufacturing Agreement

with Newport Laboratories 43

BOEHRINGER INGELHEIM Animal Health Signs Research License Deal

with Vivalis 43

AviTech Selects Merial as a Distributor and Service Provider 43

Bayer Inks Agreement with Juvaris 44

Pfizer Inks Agreement with ImmunoVaccine Technologies 44

BioVet Inaugurates BSL-4 Production Unit in India 44

Vaxine to Take over Protein Sciences 44

Pfizer Inaugurates a New Development Facility for Veterinary

Vaccines 44

Merial to Establish Animal Vaccine Manufacturing Plant 44

BNC Bioniche Life Sciences Bags Approval to Sell Econiche

Vaccines 45

Hind Bio-Pharmaceuticals to Establish Animal Vaccines Division 45

Pfizer's Animal Health Unit Acquires Schering-Plough's Product

License in Europe 45

Grupo Mathiesen Takes Over Centro de Diagnostico Veterinario 45

Harbin Veterinary Research Institute Opens Animal Vaccine

Manufacturing Base 46

Bioject Medical Technologies Enters into a Long-Term Supply,

Development and License Contract with Merial 46

Vivalis SA Signs Letter of Intent with Intervet/ Schering-Plough 46

Biochemiq Enters into Partnership with Labovet 46

Microbix Biosystems Purchases Production Plant 47

Beijing Veterinary Biological Product Factory Starts Operation

in New Plant 47

Changzhou Tongtai Biopharmaceutical Sets Up Rabies Vaccine

Facility 47

Schering-Plough to Sell Health Products of Animals to Pfizer

and Virbac 47

Pfizer Group Establishes a Veterinary Vaccines Development Center 47

Phylaxia to Acquire Gazdasagi Radio and Kozep-europai

Gazterminal Zrt 48

Bayer HealthCare AG's Animal Health Unit Enters into Licensing

Agreement with Juvaris BioTherapeutics 48

Vivalis Enters into a Commercial License Contract with Virbac 48

ImmunoVaccine Technologies Signs Licensing Agreement with

Pfizer Animal Health 48

Kaketsuken and Vivalis Extends Research Collaboration 48

Heska Amends Distribution Contract with Agri Laboratories 49

Prevtec Microbia and Saskatchewan Research Council Receives

Approval to Market and Manufacture Coliprotec 49

Imugene and Merial Enter into an Agreement 49

Celldex Therapeutics Merges with AVANT Immunotherapeutics'

Subsidiary 49

Ceva Sante Animale Acquires Delvet 50

Inovio Biomedical Signs Merger Agreement with VGX Pharmaceuticals 50

Environmental Risk Management Authority Approves equine

Influenza Vaccine 50

Functional Technologies Commences Operations of Phyterra Bio 50

Summit VetPharm Enters into Distribution Partnership with

Webster Veterinary Unit 51

PerOs Receives Establishment and Bacterin License from USDA 51

Wyeth's Fort Dodge Animal Health Unit Acquires Poultry Vaccines 51

Boehringer Ingelheim Vetmedica Receives Approval for Express®

FP and Express® Vaccines from the USDA 52

9. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 53

Merial Bags Major Australian Contract 53

United States Department of Agriculture Approves Intervet Vaccine 53

Merial Pockets Ancare 53

Heska Revises Distribution Agreement with AgriLabs 53

Animal Health International Acquires Kane Veterinary Supplies 54

Industrial Equity Investments Pockets Arysta LifeScience 54

Henry Schein Acquires W&J Dunlop 54

Tecnovax Establishes New Facility 54

Pingtung Agricultural to Set Up an Exclusive Veterinary Park 54

Ouro Fino To Expand Veterinary Product Suite 54

Alpharma Acquires Yantai Jinhai 54

Pfizer Animal Health Acquires Embrex 55

Schering-Plough Acquires Intervet 55

Schering-Plough Acquires Organon BioSciences 55

Intervet Sets Up New Animal Vaccine Production Facility in

Boxmeer 55

Crucell Licenses PER.C6® Technology to Pfizer Animal Health 56

Central Veterinary Research Laboratory to Synthesize New

Animal Vaccines 56

Pfizer to Shut Down Omaha Animal Vaccine Center 56

IGI Licenses Novasomes to Novavax 57

Bogor Agricultural Institute Collaborates with Shigeta Animal

Pharmaceuticals 57

Suguna Poultry Steps into Livestock Vaccine Production Business 57

European Medicines Agency Grants Community Authorization for

Nobilis Influenza H7N1 57

AVANT Immunotherapeutics & Pfizer Collaborate to Develop

Animal Vaccines 58

Intervet International Acquires FMD Vaccine Production

Facility from Bayer Healthcare 58

Canadian Food Inspection Agency Authorizes Bioniche E. Coli

O157:H7 Cattle Vaccine for Field Use 58

Hemispherx Biopharma Acquires DOGS Molecule Patent 59

Hind Industries to Establish Animal Vaccine Formulations Plant

at Patiala 59

Cryosite and Animal Health Australia Form Partnership 59

Hester Pharmaceuticals Plans Capacity Expansion 59

Biovet to Set up Animal Vaccine Plant in Karnataka 59

Bogor Institute of Agricultureand Shigeta Establish JV for

Production of CLOSE 5.1 Vaccine 59

IPB Shigeta Acquires Bird Flu Vaccine Rights from MedImmune 60

Bioject Medical Technologies Signs Three Agreements WithMerial 60

PetCARE Television Network signs Distribution Agreement with

Butler Animal Health Supply 60

Poultry Vaccine to be produced in Vladimir 60

10. RESEARCH AND DEVELOPMENT IN RECENT PAST 61

Scientists Develop New Vaccine Against Disease Related to PCV2 61

Auburn University and Vaxin Researchers Develop Avian Flu Vaccine 61

UK Researchers Develop In-Shell Vaccine for Chicks 61

Researchers in Vietnam Decode the H5N1 Virus Gene 62

Pittsburgh Researchers Create Avian Flu Vaccine from H5N1 Virus 62

University of Warwick Develops Protecting Virus Method 62

New Treatment Measure Against Ovine Salmonella & Brucellosis 63

ICAR Develops Indigenous Bird Flu Vaccine 63

St. Jude Develops Flu Virus Vaccine through Reverse Genetics 63

Researchers Develop Vaccine for Swine Disease 63

Researchers Develop Experimental Vaccine Against 1918

Influenza Virus 64

Study Proves Effectiveness of Intradermal Vaccine

Administration in Rabbits 64

CEL-SCI's CEL-1000 Peptide Shows Adjuvant Activity 65

Progress in Vaccine for Canine Cancer 65

11. FOCUS ON SELECT GLOBAL PLAYERS 66

Bayer HealthCare AG (Germany) 66

Biogenesis-Bago (Argentina) 66

Fort Dodge Animal Health (US) 66

Heska Corporation (US) 67

Imugene Limited (Australia) 67

Indian Immunologicals Ltd (India) 67

Lohmann Animal Health (US) 68

Merck & Co., Inc. (US) 68

Intervet/Schering-Plough Animal Health (The Netherlands) 68

Merial Ltd. (US) 69

Pfizer, Inc. (US) 69

Embrex, Inc. (US) 69

Protein Sciences Corporation (US) 70

Virbac Corporation (US) 70

12. GLOBAL MARKET PERSPECTIVE 71

Table 3: World Recent Past, Current & Future Analysis for

Veterinary Vaccines by Geographic Region - US, Europe and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 71

Table 4: World Historic Review Veterinary Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 72

Table 5: World 11-Year Perspective for Veterinary Vaccines by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015(includes corresponding Graph/Chart) 73

Table 6: World Recent Past, Current & Future Analysis for

Companion Animal Vaccines by Geographic Region - US, Europe

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 74

Table 7: World Historic Review for Companion Animal Vaccines

by Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 75

Table 8: World 11-Year Perspective for Companion Animal

Vaccines by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Europe and Rest of World Markets for Years 2005,

2010 & 2015 (includes corresponding Graph/Chart) 76

Table 9: World Recent Past, Current & Future Analysis for

Companion Animal Vaccines by Product Segment- Canine Vaccines &

Feline Vaccines Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 77

Table 10: World Historic Review for Companion Animal Vaccines

by Product Segment- Canine Vaccines & Feline Vaccines Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 78

Table 11: World 11-Year Perspective for Companion Animal

Vaccines by Product Segment - Percentage Breakdown of Dollar

Sales for Canine Vaccines & Feline Vaccines Markets for Years

2005, 2010 & 2015 78

Table 12: World Recent Past, Current & Future Analysis for

Canine Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 79

Table 13: World Historic Review for Canine Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 80

Table 14: World 11-Year Perspective for Canine Vaccines by

Geographic region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 81

Table 15: World Recent Past, Current & Future Analysis for

Feline Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 82

Table 16: World Historic Review for Feline Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 83

Table 17: World 11-Year Perspective for Feline Vaccines by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015(includes corresponding Graph/Chart) 84

Table 18: World Recent Past, Current & Future Analysis for

Livestock Vaccines by Geographic Region - US, Europe and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 85

Table 19: World Historic Review for Livestock Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 86

Table 20: World 11-Year Perspective for Livestock Vaccines by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 87

Table 21: World Recent Past, Current & Future Analysis for

Livestock Vaccines by Product Segment - Porcine Vaccines,

Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine

Vaccines and Other Animal Vaccines Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2007 through 2015 (includes corresponding Graph/Chart) 88

Table 22: World Historic Review for Livestock Vaccines by

Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry

Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal

Vaccines Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 89

Table 23: World 11-Year Perspective for Livestock Vaccines by

Product Segment - Percentage Breakdown of Dollar Sales for

Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, Equine Vaccines & Other Animal Vaccines Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 90

Table 24: World Recent Past, Current & Future Analysis for

Porcine Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 91

Table 25: World Historic Review for Porcine Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 92

Table 26: World 11-Year Perspective for Porcine Vaccines by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 93

Table 27: World Recent Past, Current and Future Analysis for

Bovine Vaccines by Geographic Region - US, Europe & Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 94

Table 28: World Historic Review for Bovine Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 95

Table 29: World 11-Year Perspective for Bovine Vaccines by

Geographic region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015(includes corresponding Graph/Chart) 96

Table 30: World Recent Past, Current & Future Analysis for

Poultry Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 97

Table 31: World Historic Review for Poultry Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 98

Table 32: World 11-Year Perspective for Poultry Vaccines by

Geographic region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 99

Table 33: World Recent Past, Current & Future Analysis for

Ovine Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 100

Table 34: World Historic Review for Ovine Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 101

Table 35: World 11-Year Perspective for Ovine Vaccines by

Geographic region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015(includes corresponding Graph/Chart) 102

Table 36: World Recent Past, Current & Future Analysis for

Equine Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 103

Table 37: World Historic Review for Equine Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 104

Table 38: World 11-Year Perspective for Equine Vaccines by

Geographic region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 105

Table 39: World Recent Past, Current & Future Analysis for

Other Animal Vaccines by Geographic Region - US, Europe and

Rest of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 106

Table 40: World Historic Review for Other Animal Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 107

Table 41: World 11-Year Perspective for Other Animal Vaccines

by Geographic region - Percentage Breakdown of Dollar Sales

for US, Europe and Rest of World Markets for Years 2005, 2010

& 2015(includes corresponding Graph/Chart) 108

13. THE UNITED STATES 109

A.Market Analysis 109

Current & Future Analysis 109

H5N1 Virus: A Conundrum for the US Industry 109

Rabies Cases in the US 109

B.Market Analytics 110

Table 42: US Recent Past, Current & Future Analysis for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other

Animal Vaccines) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 110

Table 43: US Historic Review for Veterinary Vaccines by

Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, Equine Vaccines and Other Animal Vaccines) Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 111

Table 44: US 11-Year Perspective for Veterinary Vaccines by

Product Group/Segment - Percentage Breakdown of Dollar Sales

for Companion Animal Vaccines (Canine Vaccines and Feline

Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine

Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines

and Other Animal Vaccines) Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 112

14. EUROPE 113

A.Market Analysis 113

Current & Future Analysis 113

By Region 113

By Product Segment 113

B.Market Analytics 114

Table 45: European Recent Past, Current & Future Analysis

for Veterinary Vaccines by Geographic Region - France,

Germany, Italy, United Kingdom and Rest of Europe Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 114

Table 46: European Historic Review for Veterinary Vaccines

by Geographic Region - France, Germany, Italy, United

Kingdom and Rest of Europe Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 115

Table 47: European 11-Year Perspective for Veterinary

Vaccines by Geographic Region - Percentage Breakdown of

Dollar Sales for France, Germany, Italy, United Kingdom and

Rest of Europe for Years 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 116

Table 48: European Recent Past, Current & Future for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other

Animal Vaccines) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 117

Table 49: European Historic Review for Veterinary Vaccines

by Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, Equine Vaccines and Other Animal Vaccines) Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 118

Table 50: European 11-Year Perspective for Veterinary

Vaccines by Product Group/Segment - Percentage Breakdown of

Dollar Sales for Companion Animal Vaccines (Canine Vaccines

and Feline Vaccines) and Livestock Vaccines (Porcine

Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,

Equine Vaccines and Other Animal Vaccines) Markets for Years

2005, 2010 & 2015(includes corresponding Graph/Chart) 119

14a. FRANCE 120

Market Analysis 120

Table 51: French Recent Past, Current & Future Analysis for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines and Equine Vaccines)

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 121

Table 52: French Historic Review for Veterinary Vaccines by

Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, and Equine Vaccines) Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 122

Table 53: French 11-Year Perspective for Veterinary Vaccines

by Product Group/Segment - Percentage Breakdown of Dollar

Sales for Companion Animal Vaccines (Canine Vaccines and

Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,

Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine

Vaccines) Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 123

14b. GERMANY 124

Market Analysis 124

Table 54: German Recent Past, Current & Future Analysis for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines and Equine Vaccines)

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 125

Table 55: German Historic Review for Veterinary Vaccines by

Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines and Equine Vaccines) Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 126

Table 56: German 11-Year Perspective for Veterinary Vaccines

by Product Group/ Segment - Percentage Breakdown of Dollar

Sales for Companion Animal Vaccines (Canine Vaccines and

Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,

Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine

Vaccines) Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 127

14c. ITALY 128

Market Analysis 128

Table 57: Italian Recent Past, Current & Future Analysis for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other

Animal Vaccines) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 129

Table 58: Italian Historic Review for Veterinary Vaccines by

Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, Equine Vaccines and Other Animal Vaccines) Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 130

Table 59: Italian 11-Year Perspective for Veterinary

Vaccines by Product Group/Segment - Percentage Breakdown of

Dollar Sales for Companion Animal Vaccines (Canine Vaccines

and Feline Vaccines) and Livestock Vaccines (Porcine

Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,

Equine Vaccines and Other Animal Vaccines) Markets for 2005,

2010 & 2015 (includes corresponding Graph/Chart) 131

14d. THE UNITED KINGDOM 132

Market Analysis 132

Table 60: UK Recent Past, Current & Future Analysis for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other

Animal Vaccines) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 133

Table 61: UK Historic Review for Veterinary Vaccines by

Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, Equine Vaccines and Other Animal Vaccines) Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 134

Table 62: UK 11-Year Perspective for Veterinary Vaccines by

Product Group/Segment - Percentage Breakdown of Dollar Sales

for Companion Animal Vaccines (Canine Vaccines and Feline

Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine

Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines

and Other Animal Vaccines) Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 135

14e. REST OF EUROPE 136

A.Market Analysis 136

Current & Future Analysis 136 A Note on Danish Veterinary

Services 136

The 2002 Standards of Danish Medicines recommend test for

antibody inducing fragments in veterinary vaccines 137

Hungary Vaccinates Birds Across Zoos 137

Russia Mass-Produces Vaccines Against Avian Flu 138

B.Market Analytics 138

Table 63: Rest of Europe Recent Past, Current & Future

Analysis for Veterinary Vaccines - by Product Group/ Segment

for Companion Animal Vaccines (Canine Vaccines and Feline

Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine

Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines

and Other Animal Vaccines) Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 138

Table 64: Rest of Europe Historic Review for Veterinary

Vaccines by Product Group/Segment - Companion Animal

Vaccines (Canine Vaccines and Feline Vaccines) and Livestock

Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry

Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal

Vaccines) Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 139

Table 65: Rest of Europe 11-Year Perspective for Veterinary

Vaccines by Product/Segment - Percentage Breakdown of Dollar

Sales for Companion Animal Vaccines (Canine Vaccines and

Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,

Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine

Vaccines and Other Animal Vaccines) Markets for 2005, 2010 &

2015 (includes corresponding Graph/Chart) 140

15. REST OF WORLD 141

A.Market Analysis 141

Current & Future Analysis 141

Focus on Select Regions 141

Canada 141

Overview of Canadian Animal Health Industry 141

Import and Manufacture of Veterinary Biologics 141

First to Access E. coli 0157:H7 Vaccine 142

China 142

A Glance at the Animal Vaccine Market in China 142

China Initiates Mass Vaccination Campaign Against Bird Flu

Virus 143

Australia 143

A Note on Australian Veterinary Therapeutics Market 143

India 143

ICAR Develops Indigenous Bird Flu Vaccine 143

Thailand 144

Japan & Thailand to Cooperate for Developing Bird Flu Vaccine 144

Taiwan 144

Taiwan's Animal Healthcare Industry Under Scan 144

Malaysia 144

Malaysia Initiates Measures to Deal with Potential Flu

Pandemic 144

Kazakhstan 145

Kazakhstan Takes Proactive Measures Against Bird Flu 145

North Korea 145

North Korea Develops Bird Flu Vaccine 145

Vietnam 145

Vietnam Imports Bird Flu Vaccines 145

Egypt 145

Egypt Reports H5N1 Infection in Vaccinated Flocks 145

Kenya 146

Kenya Mass-Manufactures Vaccines Against Rift Valley Fever 146

B.Market Analytics 146

Table 66: Rest of World Recent Past, Current & Future

Analysis for Veterinary Vaccines - by Product Group/ Segment

for Companion Animal Vaccines (Canine Vaccines and Feline

Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine

Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines

and Other Animal Vaccines) Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 146

Table 67: Rest of World Historic Review for Veterinary

Vaccines by Product Group/Segment - Companion Animal

Vaccines (Canine Vaccines and Feline Vaccines) and Livestock

Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry

Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal

Vaccines) Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 147

Table 68: Rest of World 11-Year Perspective for Veterinary

Vaccines by Product Group/Segment - Percentage Breakdown of

Dollar Sales for Companion Animal Vaccines (Canine Vaccines

and Feline Vaccines) and Livestock Vaccines (Porcine

Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,

Equine Vaccines and Other Animal Vaccines) Markets for 2005,

2010 & 2015 (includes corresponding Graph/Chart) 148

COMPETITIVE LANDSCAPE

Total Companies Profiled: 60 (including Divisions/Subsidiaries - 101)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 31

Canada 2

Japan 3

Europe 33

France 2

Germany 9

The United Kingdom 4

Italy 2

Rest of Europe 16

Asia-Pacific (Excluding Japan) 25

Latin America 1

Africa 1

Middle-East 5

------------------------------------------

To order this report:Veterinary healthcare Industry: Global Veterinary Vaccines Industry

Veterinary healthcare Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds Global Urological Catheters Industry
2. Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020
3. Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020
4. Reportlinker Adds Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies Adoption of New Sales Models and Technologies
5. Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth
6. Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012
7. Reportlinker Adds European RIS/PACS Market
8. Reportlinker Adds U.S. Venous Access Catheter Market
9. Reportlinker Adds Pharmaceutical Contract Manufacturing: Industry and Market Prospects 2010-2025
10. Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition
11. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ORLANDO, Fla. , Feb. 10, 2016 /PRNewswire/ ... of technologies and products that help uncover the ... and Swift Biosciences Inc., a developer of innovative ... collaboration and co-marketing partnership aimed at enabling translational ... few as a couple hundred tumor and normal ...
(Date:2/10/2016)... Fla. , Feb. 9, 2016  Until recently, ... were surgery or liposuction. Thankfully, the FDA approved the ... them to death. Coolsculpting was originally approved in 2010 ... the thighs and now the chin. With this add-on ... Center can use a smaller applicator, the CoolMini, to ...
(Date:2/10/2016)... India , February 10, 2016 ... The "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic ... Trends, Technologies, Participants, and Environment" research report indicates ... worth over $149 billion by 2020 growing at ... up of companion diagnostics and targeted therapeutics and ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. ... office is now offering a variety of comprehensive procedures for facial enhancement. The ... facial volume restoration, lip enhancement and nasal reshaping. , As a result, ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Ongoing news of ... Life Care Association™ (ALCA) to conduct a survey that takes a closer look at ... today illustrates the prevalence and causes of TBI among the aging population, and identifies ...
(Date:2/10/2016)... ... February 10, 2016 , ... United Benefit Advisors (UBA), ... latest addition to its growing list of Partner Firms. S.S. Nesbitt is ... Orlando to Huntsville and in between. , Harnessing the experience and insights of ...
(Date:2/10/2016)... ... 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company ... and full year ended December 31, 2015 on Monday, February 29, 2016 after the ... investment community following the release at 4:30 PM ET. Investors interested in participating by ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... time Emmy award winner and inspirational speaker Jan Fox will serve as keynote ... Speaking Boldly will provide participants with tools to more effectively communicate with their ...
Breaking Medicine News(10 mins):